化疗药物-话题@MedSci

#化疗药物#

50篇内容 | 2199人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2218022, encodeId=8fee221802267, content=<a href='/topic/show?id=e56199944e0' target=_blank style='color:#2F92EE;'>#靶向药物#</a> <a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=一文盘点消化道恶性肿瘤化疗药物、靶向药物和治疗方案！, objectType=article, longId=837152, objectId=c83983e1526e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719199290885_5579292.jpg, objectUrl=/article/show_article.do?id=c83983e1526e, replyNumber=0, likeNumber=68, createdTime=2024-08-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c83983e1526e, moduleTitle=一文盘点消化道恶性肿瘤化疗药物、靶向药物和治疗方案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c83983e1526e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1506733, encodeId=57fc1506e337d, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=关于化疗药物的输注注意事项，这些你一定要知道！, objectType=article, longId=735319, objectId=326ce3531952, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=326ce3531952, replyNumber=0, likeNumber=89, createdTime=2022-08-10, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=326ce3531952, moduleTitle=关于化疗药物的输注注意事项，这些你一定要知道！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=326ce3531952)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506732, encodeId=e0d21506e32f5, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=这些需要预处理的化疗药物，你不可不知！, objectType=article, longId=733073, objectId=abece330736e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abece330736e, replyNumber=0, likeNumber=89, createdTime=2022-07-24, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abece330736e, moduleTitle=这些需要预处理的化疗药物，你不可不知！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abece330736e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506731, encodeId=2ee61506e31cf, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=别只关心新型抗肿瘤药物，传统化疗药物也该学学了！, objectType=article, longId=732262, objectId=00d1e32262ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00d1e32262ad, replyNumber=0, likeNumber=103, createdTime=2022-07-14, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00d1e32262ad, moduleTitle=别只关心新型抗肿瘤药物，传统化疗药物也该学学了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00d1e32262ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506730, encodeId=07371506e306d, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=一表总结，28种常用化疗药物溶媒和输注时间, objectType=article, longId=728551, objectId=6de1e28551b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6de1e28551b0, replyNumber=0, likeNumber=93, createdTime=2022-06-04, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6de1e28551b0, moduleTitle=一表总结，28种常用化疗药物溶媒和输注时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6de1e28551b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506729, encodeId=52871506e2910, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=Eur Urol：转移去势抵抗性前列腺癌中，一线化疗药物cabazitaxel和docetaxel的患者偏好性, objectType=article, longId=221370, objectId=59592213e0c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59592213e0c8, replyNumber=0, likeNumber=102, createdTime=2021-12-02, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59592213e0c8, moduleTitle=Eur Urol：转移去势抵抗性前列腺癌中，一线化疗药物cabazitaxel和docetaxel的患者偏好性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59592213e0c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506728, encodeId=70261506e2878, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=JAMA Netw Open：铂类化疗药物基础上加用硫代硫酸钠，患者的耳毒性风险是否会更低？, objectType=article, longId=215264, objectId=bc462152649e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc462152649e, replyNumber=0, likeNumber=109, createdTime=2021-08-05, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc462152649e, moduleTitle=JAMA Netw Open：铂类化疗药物基础上加用硫代硫酸钠，患者的耳毒性风险是否会更低？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc462152649e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506727, encodeId=7d2d1506e27af, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=Br J Cancer：抗EGFR疗法治疗结直肠癌的亚型特异性疗效取决于化疗药物选择, objectType=article, longId=214205, objectId=f8bf2142050d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8bf2142050d, replyNumber=0, likeNumber=117, createdTime=2021-07-15, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8bf2142050d, moduleTitle=Br J Cancer：抗EGFR疗法治疗结直肠癌的亚型特异性疗效取决于化疗药物选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8bf2142050d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506726, encodeId=60941506e26ca, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle= Nat Nanotech：诱骗癌细胞摄取化疗药物，增强癌症治疗效果, objectType=article, longId=211472, objectId=bfc62114e25e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfc62114e25e, replyNumber=0, likeNumber=86, createdTime=2021-05-19, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfc62114e25e, moduleTitle= Nat Nanotech：诱骗癌细胞摄取化疗药物，增强癌症治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfc62114e25e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506725, encodeId=c2be1506e254d, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=化疗药物剂量如何把握？新的里程碑研究为有效监测癌症患者的化疗药物水平带来希望, objectType=article, longId=209580, objectId=07d02095806b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07d02095806b, replyNumber=0, likeNumber=86, createdTime=2021-04-06, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07d02095806b, moduleTitle=化疗药物剂量如何把握？新的里程碑研究为有效监测癌症患者的化疗药物水平带来希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07d02095806b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506724, encodeId=f45e1506e248f, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=名家共话分子分型时代下乳腺癌化疗药物的使用策略, objectType=article, longId=198884, objectId=f78719888414, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f78719888414, replyNumber=0, likeNumber=79, createdTime=2020-08-08, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f78719888414, moduleTitle=名家共话分子分型时代下乳腺癌化疗药物的使用策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f78719888414)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506723, encodeId=480a1506e23c4, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=新型乳腺癌化疗药物艾立布林获NMPA批准上市, objectType=article, longId=183683, objectId=508b18368332, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=508b18368332, replyNumber=0, likeNumber=83, createdTime=2019-11-29, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=508b18368332, moduleTitle=新型乳腺癌化疗药物艾立布林获NMPA批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=508b18368332)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506722, encodeId=69391506e227e, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=欧盟监管机构批准默克的Keytruda联合化疗药物一线治疗非鳞状NSCLC, objectType=article, longId=148603, objectId=a63d14860340, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a63d14860340, replyNumber=0, likeNumber=73, createdTime=2018-09-12, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a63d14860340, moduleTitle=欧盟监管机构批准默克的Keytruda联合化疗药物一线治疗非鳞状NSCLC, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a63d14860340)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506721, encodeId=3a381506e218e, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=Keytruda联用化疗药物获得欧盟人用药品委员会批准用于转移性NSCLC的一线治疗, objectType=article, longId=145639, objectId=cbf01456397c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbf01456397c, replyNumber=0, likeNumber=97, createdTime=2018-08-03, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbf01456397c, moduleTitle=Keytruda联用化疗药物获得欧盟人用药品委员会批准用于转移性NSCLC的一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbf01456397c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506720, encodeId=29e21506e203e, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=Blood：阿扎胞苷联合化疗药物治疗白血病患儿的效果和安全性评估。, objectType=article, longId=126892, objectId=5c9d12689208, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c9d12689208, replyNumber=0, likeNumber=90, createdTime=2018-01-20, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c9d12689208, moduleTitle=Blood：阿扎胞苷联合化疗药物治疗白血病患儿的效果和安全性评估。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c9d12689208)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506719, encodeId=6e8e1506e199a, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=PNAS：重磅级成果！新型糖尿病药物或能促进癌细胞对化疗药物变得更加敏感, objectType=article, longId=125707, objectId=ca85125e0733, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca85125e0733, replyNumber=0, likeNumber=83, createdTime=2018-01-07, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca85125e0733, moduleTitle=PNAS：重磅级成果！新型糖尿病药物或能促进癌细胞对化疗药物变得更加敏感, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca85125e0733)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506718, encodeId=eecb1506e1858, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=经导管动脉灌注化疗药物应用原则—中国肿瘤介入专家共识, objectType=article, longId=123711, objectId=bd71123e11f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd71123e11f5, replyNumber=0, likeNumber=65, createdTime=2017-12-18, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd71123e11f5, moduleTitle=经导管动脉灌注化疗药物应用原则—中国肿瘤介入专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd71123e11f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506717, encodeId=6daa1506e173c, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=Mol Cancer Res：首次发现脂肪细胞代谢化疗药物机制！, objectType=article, longId=119490, objectId=27c4119490c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27c4119490c6, replyNumber=0, likeNumber=75, createdTime=2017-11-11, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27c4119490c6, moduleTitle=Mol Cancer Res：首次发现脂肪细胞代谢化疗药物机制！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27c4119490c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506716, encodeId=c9d91506e1661, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=《中国蒽环类化疗药物临床应用专家共识》即将发布，胡夕春、王树森、王晓稼和张剑解读共识主要内容, objectType=article, longId=119407, objectId=1f5211940e81, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f5211940e81, replyNumber=0, likeNumber=82, createdTime=2017-11-11, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f5211940e81, moduleTitle=《中国蒽环类化疗药物临床应用专家共识》即将发布，胡夕春、王树森、王晓稼和张剑解读共识主要内容, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f5211940e81)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1506715, encodeId=2a8f1506e151f, content=<a href='/topic/show?id=7b8d3358050' target=_blank style='color:#2F92EE;'>#化疗药物#</a>, objectTitle=Int J Nanomed：新型空心碳球化疗药物载体可更好的治疗食管癌, objectType=article, longId=115736, objectId=923f115e3660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=923f115e3660, replyNumber=0, likeNumber=71, createdTime=2017-10-12, rootId=0, userName=luwei03, userId=5f629793993, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=923f115e3660, moduleTitle=Int J Nanomed：新型空心碳球化疗药物载体可更好的治疗食管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=923f115e3660)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

化疗药物

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#靶向药物# #化疗药物#

一文盘点消化道恶性肿瘤化疗药物、靶向药物和治疗方案！

2024-08-01发表于上海

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

关于化疗药物的输注注意事项，这些你一定要知道！

2022-08-10

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

这些需要预处理的化疗药物，你不可不知！

2022-07-24

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

别只关心新型抗肿瘤药物，传统化疗药物也该学学了！

2022-07-14

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

一表总结，28种常用化疗药物溶媒和输注时间

2022-06-04

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

Eur Urol：转移去势抵抗性前列腺癌中，一线化疗药物cabazitaxel和docetaxel的患者偏好性

2021-12-02

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

JAMA Netw Open：铂类化疗药物基础上加用硫代硫酸钠，患者的耳毒性风险是否会更低？

2021-08-05

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

Br J Cancer：抗EGFR疗法治疗结直肠癌的亚型特异性疗效取决于化疗药物选择

2021-07-15

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

Nat Nanotech：诱骗癌细胞摄取化疗药物，增强癌症治疗效果

2021-05-19

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

化疗药物剂量如何把握？新的里程碑研究为有效监测癌症患者的化疗药物水平带来希望

2021-04-06

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

名家共话分子分型时代下乳腺癌化疗药物的使用策略

2020-08-08

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

新型乳腺癌化疗药物艾立布林获NMPA批准上市

2019-11-29

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

欧盟监管机构批准默克的Keytruda联合化疗药物一线治疗非鳞状NSCLC

2018-09-12

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

Keytruda联用化疗药物获得欧盟人用药品委员会批准用于转移性NSCLC的一线治疗

2018-08-03

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

Blood：阿扎胞苷联合化疗药物治疗白血病患儿的效果和安全性评估。

2018-01-20

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

PNAS：重磅级成果！新型糖尿病药物或能促进癌细胞对化疗药物变得更加敏感

2018-01-07

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

经导管动脉灌注化疗药物应用原则—中国肿瘤介入专家共识

2017-12-18

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

Mol Cancer Res：首次发现脂肪细胞代谢化疗药物机制！

2017-11-11

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

《中国蒽环类化疗药物临床应用专家共识》即将发布，胡夕春、王树森、王晓稼和张剑解读共识主要内容

2017-11-11

luwei03 (审核中...)

前往app查看评论内容

#化疗药物#

Int J Nanomed：新型空心碳球化疗药物载体可更好的治疗食管癌

2017-10-12

科室
- - 订阅+
  - 更多科室
工具
服务